0001140361-14-021504.txt : 20140515
0001140361-14-021504.hdr.sgml : 20140515
20140515152541
ACCESSION NUMBER: 0001140361-14-021504
CONFORMED SUBMISSION TYPE: 13F-HR
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20121231
FILED AS OF DATE: 20140515
DATE AS OF CHANGE: 20140515
EFFECTIVENESS DATE: 20140515
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Ridgeback Capital Investments L.P.
CENTRAL INDEX KEY: 0001423994
IRS NUMBER: 000000000
STATE OF INCORPORATION: E9
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 13F-HR
SEC ACT: 1934 Act
SEC FILE NUMBER: 028-12856
FILM NUMBER: 14846668
BUSINESS ADDRESS:
STREET 1: 75 NINTH AVENUE
STREET 2: 5TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10011
BUSINESS PHONE: 212-808-7729
MAIL ADDRESS:
STREET 1: 75 NINTH AVENUE
STREET 2: 5TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10011
13F-HR
1
primary_doc.xml
13F-HR
LIVE
false
true
false
0001423994
XXXXXXXX
12-31-2012
12-31-2012
Ridgeback Capital Investments L.P.
75 NINTH AVENUE
5TH FLOOR
NEW YORK
NY
10011
13F HOLDINGS REPORT
028-12856
Y
Ridgeback Capital Investments Ltd. is the general partner of Ridgeback Capital Investments L.P. Pursuant to an investment management agreement, Ridgeback Capital Management LP maintains investment and voting power with respect to the securities held or controlled by Ridgeback Capital Investments Ltd. Wayne Holman, an individual, controls Ridgeback Capital Management LP. Ridgeback Capital Management LP, Ridgeback Capital Investments Ltd. and Wayne Holman do not own any securities reported herein directly.
Ridgeback Capital Investments Ltd., as General Partner, by Bud Holman
Director
212-808-7729
/s/ Bud Holman
New York
NY
05-15-2014
2
2
34220
true
1
0001357610
028-12280
Ridgeback Capital Management LP
2
0001358916
028-12277
Ridgeback Capital Investments Ltd.
INFORMATION TABLE
2
form13fInfoTable.xml
CELLDEX THERAPEUTICS INC
Common Stock
15117B103
25529
3804646
SH
SOLE
1,2
0
0
3804646
IRONWOOD PHARMACEUTICALS INC
Common Stock
46333X108
8691
784381
SH
SOLE
1,2
0
0
784381